Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04980430 · ClinicalTrials.gov registry record
Community Interest in Vision Screening Technology
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT04980430 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,000 participants.
The verdict
NCT04980430 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Virtual reality (VR) is a relatively new, emerging field within healthcare. Studies have analyzed public perceptions of virtual reality in healthcare using social media, but few have actually demonstrated and educated these modalities to communities. Because vision care can be costly and inaccessible, especially in communities with few physicians, this study aims to evaluate whether communities would be open to new technology. For example, it has been determined that 80% of vision loss is preventable with adequate screening technology, a key factor in ameliorating the economic and emotional burden of eye disease. Therefore, through demonstrations and educational presentations by medical students, gaps in understanding perceptions, willingness to adopt, and general demographics of those seeking better eye care will be understood.
Interventions
- DEVICE Virtual Reality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2022-10-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04980430
The ClinicalTrials.gov registry entry for NCT04980430 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality is the first listed.
NCT04980430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04980430 about?
NCT04980430 is a clinical study titled "Community Interest in Vision Screening Technology". Virtual reality (VR) is a relatively new, emerging field within healthcare. Studies have analyzed public perceptions of virtual reality in healthcare using social media, but few have actually demonstrated and educated these modalities to communities. Because vision care can be costly and inaccessibl...
What is the current status of trial NCT04980430?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2020-10-01. Estimated completion is 2022-10-20.
What interventions are being tested in trial NCT04980430?
The interventions under investigation include: Virtual Reality (DEVICE).
Who is sponsoring clinical trial NCT04980430?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.